493 related articles for article (PubMed ID: 25239005)
21. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.
Mathieu R; Klatte T; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Bensalah K; Lotan Y; Rink M; Kluth LA; Scherr DS; Robinson BD; Shariat SF
Urol Oncol; 2015 Nov; 33(11):495.e15-22. PubMed ID: 26228160
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy.
Liu W; Zhou Z; Dong D; Sun L; Zhang G
Yonsei Med J; 2019 Feb; 60(2):174-181. PubMed ID: 30666839
[TBL] [Abstract][Full Text] [Related]
23. Peripelvic/periureteral fat invasion is independently associated with worse prognosis in pT3 upper tract urothelial carcinoma.
Park J; Park S; Song C; Hong JH; Kim CS; Ahn H
World J Urol; 2014 Feb; 32(1):157-63. PubMed ID: 23568447
[TBL] [Abstract][Full Text] [Related]
24. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival.
Belsante M; Darwish O; Youssef R; Bagrodia A; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539
[TBL] [Abstract][Full Text] [Related]
25. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.
Kuroda K; Asakuma J; Horiguchi A; Tasaki S; Yoshii H; Sato A; Ito K; Seguchi K; Sumitomo M; Asano T
Urol Int; 2012; 88(2):225-31. PubMed ID: 22236640
[TBL] [Abstract][Full Text] [Related]
27. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
[TBL] [Abstract][Full Text] [Related]
28. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
29. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract.
Kikuchi E; Horiguchi Y; Nakashima J; Hatakeyama N; Matsumoto M; Nishiyama T; Murai M
J Urol; 2005 Dec; 174(6):2120-3; discussion 2124. PubMed ID: 16280740
[TBL] [Abstract][Full Text] [Related]
30. Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy: association with primary tumor location.
Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Kobayashi H; Ide H; Miyazaki Y; Obata J; Hoshino K; Shirotake S; Akita H; Kosaka T; Miyajima A; Momma T; Nakagawa K; Hasegawa S; Nakajima Y; Jinzaki M; Oya M
Ann Surg Oncol; 2014 Mar; 21(3):1038-45. PubMed ID: 24217788
[TBL] [Abstract][Full Text] [Related]
31. Extraurothelial recurrence after radical nephroureterectomy: preoperative predictors and survival.
Dzamic Z; Milojevic B; Kajmakovic B; Grozdic Milojevic I; Bojanic N; Sipetic Grujicic S
Int Urol Nephrol; 2015 May; 47(5):775-9. PubMed ID: 25772384
[TBL] [Abstract][Full Text] [Related]
32. Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?
Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
World J Urol; 2017 Apr; 35(4):665-673. PubMed ID: 27502934
[TBL] [Abstract][Full Text] [Related]
33. The effect of tumor location on oncologic outcomes in patients with upper urinary tract urothelial carcinoma stratified by pathologic stage.
Tai YS; Chen CH; Huang CY; Tai HC; Wang SM; Pu YS
Urol Oncol; 2016 Jan; 34(1):4.e19-25. PubMed ID: 26351152
[TBL] [Abstract][Full Text] [Related]
34. Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma.
Williams AK; Kassouf W; Chin J; Rendon R; Jacobsen N; Fairey A; Kapoor A; Black P; Lacombe L; Tanguay S; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Izawa JI
Urol Oncol; 2013 Oct; 31(7):1161-5. PubMed ID: 23415596
[TBL] [Abstract][Full Text] [Related]
35. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
Rink M; Ehdaie B; Cha EK; Green DA; Karakiewicz PI; Babjuk M; Margulis V; Raman JD; Svatek RS; Fajkovic H; Lee RK; Novara G; Hansen J; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Fisch M; Scherr DS; Shariat SF; ;
Eur Urol; 2012 Oct; 62(4):677-84. PubMed ID: 22349570
[TBL] [Abstract][Full Text] [Related]
36. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.
Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D
World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636
[TBL] [Abstract][Full Text] [Related]
37. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
Fritsche HM; Novara G; Burger M; Gupta A; Matsumoto K; Kassouf W; Sircar K; Zattoni F; Walton T; Tritschler S; Baba S; Bastian PJ; Martínez-Salamanca JI; Seitz C; Otto W; Wieland WF; Karakiewicz PI; Ficarra V; Hartmann A; Shariat SF
Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
[TBL] [Abstract][Full Text] [Related]
38. Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study.
Novara G; Matsumoto K; Kassouf W; Walton TJ; Fritsche HM; Bastian PJ; Martínez-Salamanca JI; Seitz C; Lemberger RJ; Burger M; El-Hakim A; Baba S; Martignoni G; Gupta A; Karakiewicz PI; Ficarra V; Shariat SF
Eur Urol; 2010 Jun; 57(6):1064-71. PubMed ID: 20071073
[TBL] [Abstract][Full Text] [Related]
39. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
[TBL] [Abstract][Full Text] [Related]
40. The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection.
Katz MD; Serrano MF; Humphrey PA; Grubb RL; Skolarus TA; Gao F; Kibel AS
Urol Oncol; 2011; 29(6):738-44. PubMed ID: 19914106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
